Arrhythmogenic right ventricular dysplasia/cardiomyopathy

References

• Frank R, Fontaine G, Vedel J et al. Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia. Arch. Mal Coeur Vaiss.71(9), 963–972 (1978).
   PubMedGoogle Scholar
• Corrado, D, Basso C, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol. Rev.9(5), 259–265 (2001).
   Google Scholar
• Thiene G, Basso C. Arrhythmogenic right ventricular cardiomyopathy: an update. Cardiovasc. Pathol.10(3), 109–117 (2001).
   PubMed Web of Science ®Google Scholar
• Marcus FI, Fontaine GH, Guiraudon G et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation65(2), 384–398 (1982).
   PubMed Web of Science ®Google Scholar
• Kies P, Bootsma M, Bax J, Schalij MJ, van der Wall EE. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm3(2), 225–234 (2006).
   Google Scholar
• Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation110(14), 1879–1884 (2004).
   PubMed Web of Science ®Google Scholar
• Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA276(3), 199–204 (1996).
   PubMed Web of Science ®Google Scholar
• Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N. Engl. J. Med.318(3), 129–133 (1988).
   PubMed Web of Science ®Google Scholar
• Tabib A, Loire R, Chalabreysse L et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation108(24), 3000–3005 (2003).
   PubMed Web of Science ®Google Scholar
• Peters S. Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Int. J. Cardiol.113(1), 4–11 (2006).
   PubMed Web of Science ®Google Scholar
• Corrado D, Basso C, Thiene G et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J. Am. Coll. Cardiol.30(6), 1512–1520 (1997).
   PubMed Web of Science ®Google Scholar
• Frances RJ, Arrhythmogenic right ventricular dysplasia/cardiomyopathy. A review and update. Int. J. Cardiol.110(3), 279–287 (2006).
   PubMedGoogle Scholar
• Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation94(5), 983–991 (1996).
   PubMed Web of Science ®Google Scholar
• D’Amati G, Leone O, di Gioia CR et al. Arrhythmogenic right ventricular cardiomyopathy: clinicopathologic correlation based on a revised definition of pathologic patterns. Hum. Pathol.32(10), 1078–1086 (2001).
   Google Scholar
• Thiene G, Basso C, Calabrese F, Angelini A, Valente M. Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Herz25(3), 210–215 (2000).
   Google Scholar
• Dokuparti MV, Pamuru PR, Thakkar B, Tanjore RR, Nallari P. Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy. J. Hum. Genet.50(8), 375–381 (2005).
   Google Scholar
• Corrado D, Basso C, Thiene G, Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart83(5), 588–595 (2000).
   PubMed Web of Science ®Google Scholar
• Calabrese F, Basso C, Carturan E, Valente M, Thiene G, Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc. Pathol.15(1), 11–17 (2006).
   PubMed Web of Science ®Google Scholar
• Calkins H. Arrhythmogenic right-ventricular dysplasia/cardiomyopathy. Curr. Opin. Cardiol.21(1), 55–63 (2006).
   PubMed Web of Science ®Google Scholar
• Moric-Janiszewska E, Markiewicz-Loskot G. Review on the genetics of arrhythmogenic right ventricular dysplasia. Europace9(5), 259–266 (2007).
   Google Scholar
• Asimaki A, Syrris P, Wichter T, Matthias P, Saffitz JE, McKenna WJ. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet.81(5), 964–973 (2007).
   PubMed Web of Science ®Google Scholar
• McKoy G, Protonotarios N, Crosby A et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet355(9221), 2119–2124 (2000).
   PubMed Web of Science ®Google Scholar
• Yang Z, Bowles NE, Scherer SE et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Res.99(6), 646–655 (2006).
   PubMed Web of Science ®Google Scholar
• Norman M, Simpson M, Mogensen J et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation112(5), 636–642 (2005).
   PubMed Web of Science ®Google Scholar
• Rampazzo A, Nava A, Malacrida S et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet.71(5), 1200–1206 (2002).
   PubMed Web of Science ®Google Scholar
• Pilichou K, Nava A, Basso C et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation113(9), 1171–1179 (2006).
   PubMed Web of Science ®Google Scholar
• van Tintelen JP, Entius MM, Bhuiyan ZA et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation113(13), 1650–1658 (2006).
   PubMed Web of Science ®Google Scholar
• Gerull B, Heuser A, Wichter T et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet.36(11), 1162–1164 (2004).
   PubMed Web of Science ®Google Scholar
• Dalal D, Molin LH, Piccini J et al. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation113(13), 1641–1649 (2006).
   PubMed Web of Science ®Google Scholar
• Syrris P, Ward D, Evans A et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am. J. Hum. Genet.79(5), 978–984 (2006).
   PubMed Web of Science ®Google Scholar
• Tiso N, Stephan DA, Nava A et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet.10(3), 189–194 (2001).
   PubMed Web of Science ®Google Scholar
• Beffagna G, Occhi G, Nava A et al. Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc. Res.65(2), 366–373 (2005).
   PubMed Web of Science ®Google Scholar
• Dalal D, Nasir K, Bomma C et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation112(25), 3823–3832 (2005).
   PubMed Web of Science ®Google Scholar
• Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation115(13), 1710–1720 (2007).
   PubMed Web of Science ®Google Scholar
• Corrado D, Fontaine G, Marcus FI et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation. Circulation101(11), E101–E106 (2000).
   PubMed Web of Science ®Google Scholar
• Nava A, Bauce B, Basso C et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J. Am. Coll. Cardiol.36(7), 2226–2233 (2000).
   PubMed Web of Science ®Google Scholar
• Peters S. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres. J. Cardiovasc. Med. (Hagerstown)8(7), 521–526 (2007).
   PubMed Web of Science ®Google Scholar
• Marcus FI, Fontaine GH, Frank R, Gallagher JJ, Reiter MJ. Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur. Heart J.10(Suppl. D), 68–73 (1989).
   PubMed Web of Science ®Google Scholar
• Berder V, Vauthier M, Mabo P et al. Characteristics and outcome in arrhythmogenic right ventricular dysplasia. Am. J. Cardiol.75(5), 411–414 (1995).
   PubMed Web of Science ®Google Scholar
• Pinamonti B, Di Lenarda A, Sinagra G, Silvestri F, Bussani R, Camerini F. Long-term evolution of right ventricular dysplasia-cardiomyopathy. The Heart Muscle Disease Study Group. Am. Heart J.129(2), 412–415 (1995).
   Google Scholar
• McKenna WJ, Thiene G, Nava A et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br. Heart J.71(3), 215–218 (1994).
   PubMedGoogle Scholar
• Hamid MS, Norman M, Quraishi A et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J. Am. Coll. Cardiol.40(8), 1445–1450 (2002).
   PubMed Web of Science ®Google Scholar
• Marcus FI. Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am. J. Cardiol.95(9), 1070–1071 (2005).
   Google Scholar
• Nasir K, Bomma C, Tandri H et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation110(12), 1527–1534 (2004).
   PubMed Web of Science ®Google Scholar
• Peters S, Trummel M, Koehler B, Westermann KU, The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Electrocardiol40(1), 34–37 (2007).
   Google Scholar
• Peters S, Trummel M. Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited. Ann. Noninvasive Electrocardiol.8(3), 238–245 (2003).
   Google Scholar
• Nasir K, Rutberg J, Tandri H, Berger R, Tomaselli G, Calkins H. Utility of SAECG in arrhythmogenic right ventricle dysplasia. Ann. Noninvasive Electrocardiol.8(2), 112–120 (2003).
   Google Scholar
• Fontaine G, Fontaliran F, Hebert JL et al. Arrhythmogenic right ventricular dysplasia. Annu. Rev. Med.50, 17–35 (1999).
   PubMed Web of Science ®Google Scholar
• Perez Riera AR, Antzelevitch C, Schapacknik E, Dubner S, Ferreira C. Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia? J. Electrocardiol38(3), 260–263 (2005).
   Google Scholar
• Hebert JL, Chemla D, Gerard O et al. Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia. Am. J. Cardiol.93(6), 728–733 (2004).
   Google Scholar
• Daliento L, Rizzoli G, Thiene G et al. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy. Am. J. Cardiol.66(7), 741–745 (1990).
   Google Scholar
• Chiddo A, Locuratolo N, Gaglione A et al. Right ventricular dysplasia: angiographic study. Eur. Heart J.10(Suppl. D), 42–45 (1989).
   Google Scholar
• Scognamiglio R, Fasoli G, Nava A, Miraglia G, Thiene G, Dalla-Volta S. Contribution of cross-sectional echocardiography to the diagnosis of right ventricular dysplasia at the asymptomatic stage. Eur. Heart J.10(6), 538–542 (1989).
   Google Scholar
• Manyari DE, Duff HJ, Kostuk WJ et al. Usefulness of noninvasive studies for diagnosis of right ventricular dysplasia. Am. J. Cardiol.57(13), 1147–1153 (1986).
   Google Scholar
• Yoerger DM, Marcus F, Sherrill D et al. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J. Am. Coll. Cardiol.45(6), 860–865 (2005).
   PubMed Web of Science ®Google Scholar
• Prakasa KR, Wang J, Tandri H et al. Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am. J. Cardiol.100(3), 507–512 (2007).
   Google Scholar
• Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters PE. Arrhythmogenic right ventricular disease: MR imaging vs angiography. AJR Am. J. Roentgenol.161(3), 549–555 (1993).
   PubMed Web of Science ®Google Scholar
• Tandri H, Castillo E, Ferrari VA et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J. Am. Coll. Cardiol.48(11), 2277–2284 (2006).
   PubMed Web of Science ®Google Scholar
• Tandri H, Bomma C, Calkins H, Bluemke DA. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J. Magn. Reson. Imaging.19(6), 848–858 (2004).
   Google Scholar
• Menghetti L, Basso C, Nava A, Angelini A, Thiene G. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart76(6), 467–470 (1996).
   PubMed Web of Science ®Google Scholar
• van der Wall EE, Kayser HW, Bootsma MM, de Roos A, Schalij MJ. Arrhythmogenic right ventricular dysplasia: MRI findings. Herz25(4), 356–364 (2000).
   PubMed Web of Science ®Google Scholar
• Sen-Chowdhry S, Prasad SK, Syrris P et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J. Am. Coll. Cardiol.48(10), 2132–2140 (2006).
   Google Scholar
• Bomma C, Rutberg J, Tandri H et al. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Cardiovasc. Electrophysiol.15(3), 300–306 (2004).
   Google Scholar
• Tandri H, Saranathan M, Rodriguez ER et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J. Am. Coll. Cardiol.45(1), 98–103 (2005).
   PubMed Web of Science ®Google Scholar
• Tada H, Shimizu W, Ohe T et al. Usefulness of electron-beam computed tomography in arrhythmogenic right ventricular dysplasia. Relationship to electrophysiological abnormalities and left ventricular involvement. Circulation94(3), 437–444 (1996).
   Google Scholar
• Bomma C, Dalal D, Tandri H et al. Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am. J. Cardiol.100(1), 99–105 (2007).
   Google Scholar
• Maron BJ, Chaitman BR, Ackerman MJ et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation109(22), 2807–2816 (2004).
   PubMed Web of Science ®Google Scholar
• Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation86(1), 29–37 (1992).
   PubMed Web of Science ®Google Scholar
• Boulos M, Lashevsky I, Reisner S, Gepstein L. Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. J. Am. Coll. Cardiol.38(7), 2020–2027 (2001).
   PubMed Web of Science ®Google Scholar
• Marchlinski FE, Zado E, Dixit S et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation110(16), 2293–2298 (2004).
   Web of Science ®Google Scholar
• Fontaine G, Tonet J, Gallais Y et al. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr. Cardiol. Rep.2(6), 498–506 (2000).
   Google Scholar
• Dalal D, Jain R, Tandri H et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol.50(5), 432–440 (2007).
   PubMed Web of Science ®Google Scholar
• Corrado D, Leoni L, Link MS et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation108(25), 3084–3091 (2003).
   PubMed Web of Science ®Google Scholar
• Wichter T, Paul M, Wollmann C et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation109(12), 1503–1508 (2004).
   PubMed Web of Science ®Google Scholar
• Roguin A, Bomma CS, Nasir K et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol.43(10), 1843–1852 (2004).
   PubMed Web of Science ®Google Scholar
• Hodgkinson KA, Parfrey PS, Bassett AS et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J. Am. Coll. Cardiol.45(3), 400–408 (2005).
   PubMed Web of Science ®Google Scholar
• Piccini JP, Dalal D, Roguin A et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm2(11), 1188–1194 (2005).
   PubMed Web of Science ®Google Scholar
• Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Int. J. Cardiol.107(3), 360–368 (2006).
   PubMed Web of Science ®Google Scholar
• Guiraudon GM, Klein GJ, Gulamhusein SS. Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. Circulation67(2), 463–470 (1983).
   Google Scholar
• Guiraudon GM, Klein GJ, Sharma AD, Yee R, Guiraudon CM. Surgical therapy for arrhythmogenic right ventricular adiposis. Eur. Heart J.10(Suppl. D), 82–83 (1989).
   Google Scholar
• Cox JL, Bardy GH, Damiano RJ Jr et al. Right ventricular isolation procedures for nonischemic ventricular tachycardia. J. Thorac. Cardiovasc. Surg.90(2), 212–224 (1985).
   Google Scholar
• Misaki T, Watanabe G, Iwa T et al. Surgical treatment of arrhythmogenic right ventricular dysplasia: long-term outcome. Ann. Thorac. Surg.58(5), 1380–1385 (1994).
   Google Scholar
• Sano S, Ishino K, Kawada M et al. Total right ventricular exclusion procedure: an operation for isolated congestive right ventricular failure. J. Thorac. Cardiovasc. Surg.123(4), 640–647 (2002).
   Google Scholar
• Motta P, Mossad E, Savage R. Right ventricular exclusion surgery for arrhythmogenic right ventricular dysplasia with cardiomyopathy. Anesth. Analg.96(6), 1598–1602 (2003).
   Google Scholar
• Sen-Chowdhry S, Syrris P, McKenna WJ. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol.50(19), 1813–1821 (2007).
   PubMed Web of Science ®Google Scholar